TLPH Q4 2021 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2,000-99.7% YoY

Gross Profit

-$1M-61600.0% margin

Operating Income

-$8M-408750.0% margin

Net Income

-$8M-395850.0% margin

EPS (Diluted)

$-1.24

QoQ Revenue Growth

-99.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$78M

Total Liabilities

$114M

Stockholders' Equity

-$36M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2,000	$738,000	-99.7%
Gross Profit	-$1M	-$1M	+11.9%
Operating Income	-$8M	-$9M	+11.6%
Net Income	-$8M	-$9M	+11.2%